Bluejay Diagnostics, Inc. (BJDX)
2.15
+0.16
(+8.04%)
USD |
NASDAQ |
Feb 20, 10:35
Bluejay Diagnostics EPS Diluted (Quarterly) : -4.059 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.598M |
| Total Expenses (Quarterly) | 1.598M |
| Enterprise Value | -1.519M |
| Earnings Yield | -5.53K% |
| Normalized Earnings Yield | -5529.14 |